Kaufman RJ - Search Results

1

Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.

Casper ES, Raymond V, Hakes TB, Currie VE, Kaufman RJ. Casper ES, et al. Among authors: kaufman rj. Cancer Treat Rep. 1987 Dec;71(12):1289-90. Cancer Treat Rep. 1987. PMID: 3480045 No abstract available.

2

Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy.

Geller NL, Hakes TB, Petroni GR, Currie V, Kaufman R. Geller NL, et al. Cancer. 1990 Oct 15;66(8):1678-84. doi: 10.1002/1097-0142(19901015)66:8<1678::aid-cncr2820660804>3.0.co;2-r. Cancer. 1990. PMID: 2208022 Clinical Trial.

3

Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer.

Casper ES, Smart TC, Hakes TB, Ochoa M Jr, Kaufman RJ. Casper ES, et al. Among authors: kaufman rj. Invest New Drugs. 1988 Jun;6(2):87-91. doi: 10.1007/BF00195365. Invest New Drugs. 1988. PMID: 3049433 Clinical Trial.

4

Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer.

Andrykowski MA, Jacobsen PB, Marks E, Gorfinkle K, Hakes TB, Kaufman RJ, Currie VE, Holland JC, Redd WH. Andrykowski MA, et al. Among authors: kaufman rj. Cancer. 1988 Dec 15;62(12):2607-13. doi: 10.1002/1097-0142(19881215)62:12<2607::aid-cncr2820621226>3.0.co;2-s. Cancer. 1988. PMID: 3191461

5

Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer.

Jacobsen PB, Andrykowski MA, Redd WH, Die-Trill M, Hakes TB, Kaufman RJ, Currie VE, Holland JC. Jacobsen PB, et al. Among authors: kaufman rj. Cancer. 1988 Jan 15;61(2):379-85. doi: 10.1002/1097-0142(19880115)61:2<379::aid-cncr2820610230>3.0.co;2-e. Cancer. 1988. PMID: 3334973

6

Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.

Leitner SP, Casper ES, Hakes TB, Kaufman RJ, Winn RJ, Scoppetuolo M, Raymond V, Geller NL, Young CW. Leitner SP, et al. Among authors: kaufman rj. Cancer Treat Rep. 1985 Nov;69(11):1319-20. Cancer Treat Rep. 1985. PMID: 4092194

7

Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin.

Casper ES, Guidera CA, Bosl GJ, Hakes TB, Kaufman RJ, Shurgot B, Kinne DW. Casper ES, et al. Among authors: kaufman rj. Breast Cancer Res Treat. 1987;9(1):39-44. doi: 10.1007/BF01806692. Breast Cancer Res Treat. 1987. PMID: 3593990 Clinical Trial.

8

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients.

Dnistrian AM, Schwartz MK, Fracchia AA, Kaufman RJ, Hakes TB, Currie VE. Dnistrian AM, et al. Among authors: kaufman rj. Cancer. 1983 Mar 1;51(5):803-7. doi: 10.1002/1097-0142(19830301)51:5<803::aid-cncr2820510509>3.0.co;2-v. Cancer. 1983. PMID: 6687378

9

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

Jain KK, Casper ES, Geller NL, Hakes TB, Kaufman RJ, Currie V, Schwartz W, Cassidy C, Petroni GR, Young CW, et al. Jain KK, et al. Among authors: kaufman rj. J Clin Oncol. 1985 Jun;3(6):818-26. doi: 10.1200/JCO.1985.3.6.818. J Clin Oncol. 1985. PMID: 3859587 Clinical Trial.

10

Treatment of advanced male breast cancer.

Kraybill WG, Kaufman R, Kinne D. Kraybill WG, et al. Cancer. 1981 May 1;47(9):2185-9. doi: 10.1002/1097-0142(19810501)47:9<2185::aid-cncr2820470913>3.0.co;2-b. Cancer. 1981. PMID: 6164479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters